GLUTOSIN Trademark

Trademark Overview

On Friday, April 3, 2020, a trademark application was filed for GLUTOSIN with the United States Patent and Trademark Office. The USPTO has given the GLUTOSIN trademark a serial number of 88858722. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 23, 2024. This trademark is owned by STADA Arzneimittel AG. The GLUTOSIN trademark is filed in the Pharmaceutical Products category with the following description:

Dietetic foods adapted for medical purposes; dietetic preparations adapted for medical use; nutritional supplements; pharmaceutical preparations for the treatment of gluten intolerance and celiac disease; chemico-pharmaceutical preparations for the treatment of gluten intolerance and celiac disease; sanitary preparations for medical use; dietetic foods for medical purposes; food for babies; biological preparations for medical purposes for the treatment of gluten intolerance and celiac disease; chemical preparations for medical purposes for the treatment of gluten intolerance and celiac disease; enzymes and enzyme preparations for medical purposes; ferments for medical purposes; dietetic beverages adapted for medical purposes; medicinal beverages for the treatment of gluten intolerance and celiac disease; syrups for medical purposes, for the treatment of gluten intolerance and celiac disease
glutosin

General Information

Serial Number88858722
Word MarkGLUTOSIN
Filing DateFriday, April 3, 2020
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements

Goods and ServicesDietetic foods adapted for medical purposes; dietetic preparations adapted for medical use; nutritional supplements; pharmaceutical preparations for the treatment of gluten intolerance and celiac disease; chemico-pharmaceutical preparations for the treatment of gluten intolerance and celiac disease; sanitary preparations for medical use; dietetic foods for medical purposes; food for babies; biological preparations for medical purposes for the treatment of gluten intolerance and celiac disease; chemical preparations for medical purposes for the treatment of gluten intolerance and celiac disease; enzymes and enzyme preparations for medical purposes; ferments for medical purposes; dietetic beverages adapted for medical purposes; medicinal beverages for the treatment of gluten intolerance and celiac disease; syrups for medical purposes, for the treatment of gluten intolerance and celiac disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTADA Arzneimittel AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBad Vilbel 61118
DE
Party NameSTADA Arzneimittel AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBad Vilbel 61118
DE

Trademark Events

Event DateEvent Description
Tuesday, April 7, 2020NEW APPLICATION ENTERED
Friday, April 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 16, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, June 23, 2020ASSIGNED TO EXAMINER
Friday, June 26, 2020ASSIGNED TO LIE
Friday, June 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 6, 2020NON-FINAL ACTION WRITTEN
Monday, July 6, 2020NON-FINAL ACTION E-MAILED
Monday, July 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 14, 2021SOU TEAS EXTENSION RECEIVED
Monday, June 14, 2021SOU EXTENSION 1 FILED
Monday, June 14, 2021SOU EXTENSION 1 GRANTED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 29, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 29, 2021SOU EXTENSION 2 FILED
Wednesday, December 29, 2021SOU EXTENSION 2 GRANTED
Friday, December 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 11, 2022SOU TEAS EXTENSION RECEIVED
Monday, July 11, 2022SOU EXTENSION 3 FILED
Monday, July 11, 2022SOU EXTENSION 3 GRANTED
Wednesday, July 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 8, 2022SOU EXTENSION 4 FILED
Thursday, December 8, 2022SOU EXTENSION 4 GRANTED
Saturday, December 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 27, 2023SOU EXTENSION 5 FILED
Monday, July 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 5, 2023SOU EXTENSION 5 GRANTED
Thursday, July 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 12, 2024NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 19, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Friday, January 26, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, March 5, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 5, 2024NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 25, 2024ASSIGNED TO PETITION STAFF
Friday, January 26, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, March 5, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, April 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

glutosin medical purposes preparations gluten treatment intolerance disease celiac dietetic adapted